Intravascular radiotherapy prevents arterial restenosis

An international trial has shown that intravascular radiotherapy can prevent artery re-narrowing after stent implantation.

Written byScience Now
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

LONDON, September 20 (SPIS MedWire). Low-dose internal radiotherapy is effective in preventing coronary artery narrowing after stent implantation, an international trial has shown.

Speaking at the European Society for Therapeutic Radiology and Oncology conference in Istanbul this week, Dr Ian Crocker from the Department of Radiation Oncology at Emory University School of Medicine, USA, presented results from the START (STents And Radiation Therapy Trial) trial, conducted in 50 North American and European centres.

"This is the first clinical trial to evaluate the safety and effectiveness of beta, rather than gamma, radiation for patients with in-stent restenosis," he said. Immediately following the procedure to open their blocked stents, 476 patients were randomized to receive either a beta radiation source (Strontium 90) for 3-5 minutes or placebo (no treatment). Eight months later, all patients returned for an angiogram.

Dr Crocker said that patients treated with beta radiation had a significant reduction in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery